<p>Oral probiotics have shown great potential in treating ulcerative colitis (UC). However, gastrointestinal obstacles substantially inactivate probiotics, impeding delivery and colonization in the colon. Here, we developed robust oral living therapeutics with high colon-accumulating effect <i>via</i> surface decoration of probiotic (<i>Escherichia coli</i> Nissle 1917, <i>EcN</i>) using a layer-by-layer approach. Calcium ions and carboxymethyl-modified lignin (CML) were sequentially coated on <i>EcN</i> to generate an acid-resistant and colitis microenvironment-responsive system (CML@<i>EcN</i>). After oral administration in a male C57BL/6 N mouse model, <i>EcN</i> were specifically delivered to the site of colitis and successfully colonized. The CML@<i>EcN</i> notably alleviated colitis by modulating immune dysfunction, reshaping gut microbiota (GM), and repairing the intestinal barrier. The delivery mechanism was explored based on experiments and mathematical models. Interestingly, this engineering approach can be further used to decorate other bacteria. Consequently, the robust CML@<i>EcN</i> shows high colon-targeting delivery efficacy and great potential in UC therapy.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Surface decoration of bacteria generates robust living therapeutics for improved ulcerative colitis therapy

  • Junyu Liu,
  • Zhihao Fang,
  • Xiaobin Li,
  • Xiaopeng Zhang,
  • Yun Chen,
  • Fujia Kou,
  • Long Huang,
  • Huanxian Yang,
  • Yilin Zheng,
  • Yuqing Huang,
  • Yi Wang,
  • Xueqing Qiu,
  • Jun Ge,
  • Yong Qian,
  • Xin-Hui Xing,
  • Can Yang Zhang

摘要

Oral probiotics have shown great potential in treating ulcerative colitis (UC). However, gastrointestinal obstacles substantially inactivate probiotics, impeding delivery and colonization in the colon. Here, we developed robust oral living therapeutics with high colon-accumulating effect via surface decoration of probiotic (Escherichia coli Nissle 1917, EcN) using a layer-by-layer approach. Calcium ions and carboxymethyl-modified lignin (CML) were sequentially coated on EcN to generate an acid-resistant and colitis microenvironment-responsive system (CML@EcN). After oral administration in a male C57BL/6 N mouse model, EcN were specifically delivered to the site of colitis and successfully colonized. The CML@EcN notably alleviated colitis by modulating immune dysfunction, reshaping gut microbiota (GM), and repairing the intestinal barrier. The delivery mechanism was explored based on experiments and mathematical models. Interestingly, this engineering approach can be further used to decorate other bacteria. Consequently, the robust CML@EcN shows high colon-targeting delivery efficacy and great potential in UC therapy.